209 related articles for article (PubMed ID: 34614280)
21. High-resolution copy number profiling by array CGH using DNA isolated from formalin-fixed, paraffin-embedded tissues.
van Essen HF; Ylstra B
Methods Mol Biol; 2012; 838():329-41. PubMed ID: 22228020
[TBL] [Abstract][Full Text] [Related]
22. Tissue recommendations for precision cancer therapy using next generation sequencing: a comprehensive single cancer center's experiences.
Cho M; Ahn S; Hong M; Bang H; Van Vrancken M; Kim S; Lee J; Park SH; Park JO; Park YS; Lim HY; Kang WK; Sun JM; Lee SH; Ahn MJ; Park K; Kim DH; Lee S; Park W; Kim KM
Oncotarget; 2017 Jun; 8(26):42478-42486. PubMed ID: 28477007
[TBL] [Abstract][Full Text] [Related]
23. Clinical significance of comprehensive genomic profiling tests covered by public insurance in patients with advanced solid cancers in Hokkaido, Japan.
Kikuchi J; Ohhara Y; Takada K; Tanabe H; Hatanaka K; Amano T; C Hatanaka K; Hatanaka Y; Mitamura T; Kato M; Shibata Y; Yabe I; Endoh A; Komatsu Y; Matsuno Y; Sugiyama M; Manabe A; Sakurai A; Takahashi M; Naruse H; Torimoto Y; Dosaka-Akita H; Kinoshita I
Jpn J Clin Oncol; 2021 Apr; 51(5):753-761. PubMed ID: 33532831
[TBL] [Abstract][Full Text] [Related]
24. Comparison of Accuracy of Whole-Exome Sequencing with Formalin-Fixed Paraffin-Embedded and Fresh Frozen Tissue Samples.
Oh E; Choi YL; Kwon MJ; Kim RN; Kim YJ; Song JY; Jung KS; Shin YK
PLoS One; 2015; 10(12):e0144162. PubMed ID: 26641479
[TBL] [Abstract][Full Text] [Related]
25. Comprehensive Screening of Gene Copy Number Aberrations in Formalin-Fixed, Paraffin-Embedded Solid Tumors Using Molecular Inversion Probe-Based Single-Nucleotide Polymorphism Array.
Singh RR; Mehrotra M; Chen H; Almohammedsalim AA; Sahin A; Bosamra A; Patel KP; Routbort MJ; Lu X; Ronald A; Mishra BM; Virani S; Medeiros LJ; Luthra R
J Mol Diagn; 2016 Sep; 18(5):676-687. PubMed ID: 27392636
[TBL] [Abstract][Full Text] [Related]
26. Next-generation sequencing of RNA and DNA isolated from paired fresh-frozen and formalin-fixed paraffin-embedded samples of human cancer and normal tissue.
Hedegaard J; Thorsen K; Lund MK; Hein AM; Hamilton-Dutoit SJ; Vang S; Nordentoft I; Birkenkamp-Demtröder K; Kruhøffer M; Hager H; Knudsen B; Andersen CL; Sørensen KD; Pedersen JS; Ørntoft TF; Dyrskjøt L
PLoS One; 2014; 9(5):e98187. PubMed ID: 24878701
[TBL] [Abstract][Full Text] [Related]
27. A predictive factor of the quality of microarray comparative genomic hybridization analysis for formalin-fixed paraffin-embedded archival tissue.
Nakao K; Oikawa M; Arai J; Mussazhanova Z; Kondo H; Shichijo K; Nakashima M; Hayashi T; Yoshiura K; Hatachi T; Nagayasu T
Diagn Mol Pathol; 2013 Sep; 22(3):174-80. PubMed ID: 23846445
[TBL] [Abstract][Full Text] [Related]
28. [Interinstitutional Collaboration for Molecular Tumor Boards].
Komine K; Shirota H
Gan To Kagaku Ryoho; 2019 Apr; 46(4):626-629. PubMed ID: 31164497
[TBL] [Abstract][Full Text] [Related]
29. Cytology smears as excellent starting material for next-generation sequencing-based molecular testing of patients with adenocarcinoma of the lung.
Velizheva NP; Rechsteiner MP; Wong CE; Zhong Q; Rössle M; Bode B; Moch H; Soltermann A; Wild PJ; Tischler V
Cancer Cytopathol; 2017 Jan; 125(1):30-40. PubMed ID: 27636102
[TBL] [Abstract][Full Text] [Related]
30. Comparison of whole-exome sequencing of matched fresh and formalin fixed paraffin embedded melanoma tumours: implications for clinical decision making.
De Paoli-Iseppi R; Johansson PA; Menzies AM; Dias KR; Pupo GM; Kakavand H; Wilmott JS; Mann GJ; Hayward NK; Dinger ME; Long GV; Scolyer RA
Pathology; 2016 Apr; 48(3):261-6. PubMed ID: 27020503
[TBL] [Abstract][Full Text] [Related]
31. [The Role of Core Hospitals and Cooperative Hospitals for Cancer Genomic Medicine in Japan].
Sunami K
Gan To Kagaku Ryoho; 2019 Apr; 46(4):617-621. PubMed ID: 31164495
[TBL] [Abstract][Full Text] [Related]
32. Multicenter validation of cancer gene panel-based next-generation sequencing for translational research and molecular diagnostics.
Hirsch B; Endris V; Lassmann S; Weichert W; Pfarr N; Schirmacher P; Kovaleva V; Werner M; Bonzheim I; Fend F; Sperveslage J; Kaulich K; Zacher A; Reifenberger G; Köhrer K; Stepanow S; Lerke S; Mayr T; Aust DE; Baretton G; Weidner S; Jung A; Kirchner T; Hansmann ML; Burbat L; von der Wall E; Dietel M; Hummel M
Virchows Arch; 2018 Apr; 472(4):557-565. PubMed ID: 29374318
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of the short-term stability of specimens for clinical laboratory testing.
Ikeda K; Ichihara K; Hashiguchi T; Hidaka Y; Kang D; Maekawa M; Matsumoto H; Matsushita K; Okubo S; Tsuchiya T; Furuta K;
Biopreserv Biobank; 2015 Apr; 13(2):135-43. PubMed ID: 25880474
[TBL] [Abstract][Full Text] [Related]
34. Early experience with formalin-fixed paraffin-embedded (FFPE) based commercial clinical genomic profiling of gliomas-robust and informative with caveats.
Movassaghi M; Shabihkhani M; Hojat SA; Williams RR; Chung LK; Im K; Lucey GM; Wei B; Mareninov S; Wang MW; Ng DW; Tashjian RS; Magaki S; Perez-Rosendahl M; Yang I; Khanlou N; Vinters HV; Liau LM; Nghiemphu PL; Lai A; Cloughesy TF; Yong WH
Exp Mol Pathol; 2017 Aug; 103(1):87-93. PubMed ID: 28663030
[TBL] [Abstract][Full Text] [Related]
35. Comprehensive evaluation and validation of targeted next-generation sequencing performance in two clinical laboratories.
Mendez P; Dang J; Kim JW; Lee S; Yoon JH; Kim T; Sailey CJ; Jablons DM; Kim IJ
Int J Oncol; 2016 Jul; 49(1):235-42. PubMed ID: 27121194
[TBL] [Abstract][Full Text] [Related]
36. High-throughput detection of clinically relevant mutations in archived tumor samples by multiplexed PCR and next-generation sequencing.
Bourgon R; Lu S; Yan Y; Lackner MR; Wang W; Weigman V; Wang D; Guan Y; Ryner L; Koeppen H; Patel R; Hampton GM; Amler LC; Wang Y
Clin Cancer Res; 2014 Apr; 20(8):2080-91. PubMed ID: 24573554
[TBL] [Abstract][Full Text] [Related]
37. [Sample Quality Control through the Depository and Distribution of Cancer-Related Human Materials: Experience of Kanagawa Cancer Research & Information Association (KCRIA)].
Miyagi Y
Rinsho Byori; 2015 Jan; 63(1):111-8. PubMed ID: 26524887
[TBL] [Abstract][Full Text] [Related]
38. C-CAT: The National Datacenter for Cancer Genomic Medicine in Japan.
Kohno T; Kato M; Kohsaka S; Sudo T; Tamai I; Shiraishi Y; Okuma Y; Ogasawara D; Suzuki T; Yoshida T; Mano H
Cancer Discov; 2022 Nov; 12(11):2509-2515. PubMed ID: 36321305
[TBL] [Abstract][Full Text] [Related]
39. Assessing the Value of Next-Generation Sequencing Tests in a Dynamic Environment.
Burris HA; Saltz LB; Yu PP
Am Soc Clin Oncol Educ Book; 2018 May; 38():139-146. PubMed ID: 30231307
[TBL] [Abstract][Full Text] [Related]
40. TargetPlex FFPE-Direct DNA Library Preparation Kit for SiRe NGS panel: an international performance evaluation study.
Malapelle U; Pepe F; Pisapia P; Sgariglia R; Nacchio M; Barberis M; Bilh M; Bubendorf L; Büttner R; Cabibi D; Castiglia M; De Andrea CE; de Biase D; Dumur CI; Fontanini G; Freire J; Gristina V; Hofman P; Ilie M; Lozano MD; Merkelbach-Bruse S; Pappesch R; Pelusi N; Roma G; Russo A; Savic S; Siemanowski J; Tallini G; Tischler V; Vander Borght S; Weynand B; Xu T; Troncone G
J Clin Pathol; 2022 Jun; 75(6):416-421. PubMed ID: 33766954
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
